Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-01

Clinical Trial Update: Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluated haloperidol with or without chlorpromazine for delirium in patients with advanced, metastatic, or recurrent cancer; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorpromazine (chlorpromazine)
  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Delirium | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-09-01